4//SEC Filing
Merrigan Kathleen 4
Accession 0001209191-18-006615
CIK 0001441693other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 8:38 PM ET
Size
21.8 KB
Accession
0001209191-18-006615
Insider Transaction Report
Form 4
Merrigan Kathleen
Director
Transactions
- Exercise/Conversion
Common Stock
2018-01-31+21,941→ 21,941 total - Exercise/Conversion
Common Stock
2018-01-31+14,201→ 76,732 total - Exercise/Conversion
Restricted Stock Units
2018-01-31−36,850→ 0 total→ Common Stock (36,850 underlying) - Exercise/Conversion
Common Stock
2018-01-31+3,740→ 25,681 total - Award
Restricted Stock Units
2018-01-30+14,201→ 14,201 total→ Common Stock (14,201 underlying) - Exercise/Conversion
Restricted Stock Units
2018-01-31−3,740→ 0 total→ Common Stock (3,740 underlying) - Exercise/Conversion
Restricted Stock Units
2018-01-31−14,201→ 0 total→ Common Stock (14,201 underlying) - Exercise/Conversion
Restricted Stock Units
2018-01-31−21,941→ 13,965 total→ Common Stock (21,941 underlying) - Exercise/Conversion
Common Stock
2018-01-31+36,850→ 62,531 total
Footnotes (5)
- [F1]Each restricted stock unit represented a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock, which settled upon the termination of the reporting person's service as a director.
- [F2]The restricted stock units vested with respect to 100% of the total shares subject to the grant on January 30, 2018. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.
- [F3]The restricted stock units vested with respect to 1/3rd of the total shares on the first anniversary of the vesting commencement date of March 22, 2016, and with respect to 1/24th of the remaining shares subject to the grant monthly thereafter for 24 months. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.
- [F4]The restricted stock units vested with respect to 100% of the total shares subject to the grant on the date of the 2016 annual stockholder meeting. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.
- [F5]The restricted stock units vested with respect to 100% of the total shares subject to the grant on the date of the 2017 annual stockholder meeting. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event.
Documents
Issuer
MARRONE BIO INNOVATIONS INC
CIK 0001441693
Entity typeother
Related Parties
1- filerCIK 0001665655
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 8:38 PM ET
- Size
- 21.8 KB